文献速递乳房整形与再造

乳头保留乳房切除术后保留包膜乳房重建在既往隆乳患者中的应用

Capsule Preservation Breast Reconstruction Following Nipple-Sparing Mastectomy in Patients With Prior Breast Augmentation.
PubMed 文献 · Ann Plast Surg · 2025-01-01

保留包膜组行一期重建比例更高(65.5% vs 13.3%,P=0.001),血清肿发生率更低(6.1% vs 47.8%,P<0.0001),两组并发症无显著差异,美容效果相当,肿瘤复发率无显著差异。

要点

  • 保留包膜组一期重建比例显著高于未保留组(65.5% vs 13.3%,P=0.001)。
  • 未保留包膜组血清肿发生率显著更高(47.8% vs 6.1%,P<0.0001)。
  • 保留包膜组肿瘤复发率0% vs 13.3%,差异无统计学意义(P=0.111)。

核心结论

  • 对于既往隆乳患者,NSM后乳房重建中保留原有包膜可能安全,不增加肿瘤复发风险。
  • 保留包膜组并发症发生率有利,美容效果相当。

研究设计与样本

  • 单术者回顾性队列研究,纳入2006年7月至2021年5月间44例(72侧乳房)既往隆乳后行NSM并乳房重建的患者。

主要发现

  • 保留包膜组NSM时平均年龄更小(49岁 vs 55岁,P=0.040)。
  • 保留包膜组一期重建比例更高(65.5% vs 13.3%,P=0.001)。
  • 肿瘤复发率保留包膜组0% vs 未保留组13.3%(P=0.111)。
  • 术后并发症无显著差异,但未保留包膜组血清肿更常见(47.8% vs 6.1%,P<0.0001)。
  • 未保留包膜组翻修手术率更高(52.2% vs 24.5%,P=0.061)。

关键数值与推荐

  • 保留包膜组一期重建比例65.5%,未保留组13.3%(P=0.001)。
  • 血清肿发生率保留包膜组6.1%,未保留组47.8%(P<0.0001)。
  • 肿瘤复发率保留包膜组0%,未保留组13.3%(P=0.111)。
  • 翻修手术率保留包膜组24.5%,未保留组52.2%(P=0.061)。

临床怎么用

  • 对既往隆乳患者行NSM后乳房重建时,可考虑保留原有包膜以争取一期重建。
  • 保留包膜可能降低血清肿和翻修手术风险,但需结合患者个体情况评估。

局限性

  • 单术者回顾性研究,样本量较小(44例患者,72侧乳房)。
  • 美容效果评估基于主要作者主观评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with prior breast augmentation provide an opportunity for capsule preservation and possible direct-to-implant breast reconstruction immediately following nipple-sparing mastectomy (NSM). However, clinical outcomes and postoperative complications remain unclearly described in current literature. METHODS: A single reconstructive surgeon retrospective cohort study was conducted on 44 patients (72 breasts) with prior breast augmentation undergoing breast reconstruction following NSM between July 2006 and May 2021. Twenty-nine patients (49 breasts) underwent capsule preservation reconstruction compared with 15 patients (23 breasts) who did not. Demographics, complications, and cosmetic outcomes between the 2 cohorts were reviewed. RESULTS: Patients with capsule preservation were on average younger at time of NSM (49 years vs 55 years; P = 0.040) and more likely to undergo 1-stage reconstruction (65.5% vs 13.3%; P = 0.001). Cancer recurrence was similar, though lower in the capsule-preserved group (0% vs 13.3%; P = 0.111). There was no significant difference in regard to postoperative complications, with the exception of seromas being more common in the noncapsule preservation group (47.8% vs 6.1%; P < 0.0001). Revision surgery rates were also higher in the noncapsule preservation group, though not statistically significant (52.2% vs 24.5%; P = 0.061). The capsule-preserved group demonstrated comparable nipple aesthetic and overall cosmesis based on the primary author's subjective review. CONCLUSIONS: For patients with prior breast augmentation, preservation of the preexisting capsule during breast reconstruction following NSM is likely safe with no increased risk of cancer recurrence, favorable complication rates, and comparable cosmetic outcomes.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Salingaros S, Paik KC, Truong AY, et al. Capsule Preservation Breast Reconstruction Following Nipple-Sparing Mastectomy in Patients With Prior Breast Augmentation. Ann Plast Surg. 2025. PMID: 40498968. doi:10.1097/SAP.0000000000004298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。